Sunday, September 15, 2024 8:07:27 AM
Yes, that is a nice interview.
A few notes from it. Around 23:30 she is disusing the actual antigen used and is talking about purified specific antigens and getting away from lysates.
"So here, you take the blood cells and they pretty normal on the surface anyway, and you can culture them in GMCSFas a growth factor, and IL-4 for differentiation. and load them with purified forms of antigen, and this is getting away from the tumor lysate where you would loading them with tumor antigens that you know about and don;t know about, which is good, and IL-10 and tgf beta and all these negative regulators."
I.E., the multiple antigens is good, but comes at a cost of negative regulators in the lysate.
Not trying to say one approach is clearly better than another. Just that many experts in the field are not able to see what the scientists on this message board assert is obvious.
Oh, she also seams to support RNA based approaches.
A few notes from it. Around 23:30 she is disusing the actual antigen used and is talking about purified specific antigens and getting away from lysates.
"So here, you take the blood cells and they pretty normal on the surface anyway, and you can culture them in GMCSFas a growth factor, and IL-4 for differentiation. and load them with purified forms of antigen, and this is getting away from the tumor lysate where you would loading them with tumor antigens that you know about and don;t know about, which is good, and IL-10 and tgf beta and all these negative regulators."
I.E., the multiple antigens is good, but comes at a cost of negative regulators in the lysate.
Not trying to say one approach is clearly better than another. Just that many experts in the field are not able to see what the scientists on this message board assert is obvious.
Oh, she also seams to support RNA based approaches.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
